Analitik Artefaktlar
Synopsis
Analytical artifacts are factors in antemortem and postmortem forensic toxicology that complicate the accurate interpretation of analytical results. In the antemortem phase, minor impurities in internal standards, structural analogs in pharmaceutical standards, solvent impurities, or drug losses during extraction and drying stages adversely affect quantitative accuracy. Examples leading to false positive or negative results include in vitro synthesis of 6-acetylmorphine from morphine and aspirin, ephedrine conversion to methamphetamine, thermal transformation of methadone to EDDP or oxcarbazepine to carbamazepine at high injector port temperatures, and nordiazepam formation during ß-glucuronidase hydrolysis. Furthermore, instrument carryover and ghost peaks cause erroneous findings. In postmortem toxicology, tissue and fluid putrefaction, postmortem ethanol and 1-propanol biosynthesis, cross-reactivity caused by putrefactive amines in immunoassays, and solvent-induced artificial adducts during chromatographic extraction (e.g., carbamate formation with chloroform or isopropyl ester formation during solid-phase elution) further complicate analysis. Therefore, maintaining broad analytical quality controls, simultaneously monitoring major metabolites and degradation products, and having findings evaluated by experienced forensic toxicologists are critically essential.
References
Bergeron A, Furtado M, Garofolo F. Importance of using highly pure internal standards for successful liquid chromatography/tandem mass spectrometric bioanalytical assays. Rapid Communications in Mass Spectrometry. 2009;23: 1287–1297. doi:10.1002/rcm
West R, West C, Crews B, et al. Anomalous observations of hydrocodone in patients on oxycodone. Clinica Chimica Acta. Elsevier B.V.; 2011;412(1–2): 29–32. doi:10.1016/j.cca.2010.08.029
West R, Crews B, Mikel C, et al. Anomalous Observations of Codeine in Patients on Morphine. Therapeutic Drug Monitoring. 2009;31(6): 776–778. doi:10.1097/FTD.0b013e3181c1082a
Herndon RL, Wade NA. Poster P-132 Presented at the SOFT-TIAFT Meeting. 2011.
Medical Review Officer (MRO) XXI. [Online] Medical Review Officer (MRO) Alert. https://www.samhsa.gov/workplace/drug-testing#Medical Review Officer (MRO) Resources
Tompsett SL. The Volatility of Amphetamine Base and Some Related Compounds. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 1971;8(1–6): 115–116. doi:10.1177/000456327100800127
Logan BK. Methamphetamine - Effects on Human Performance and Behavior. Forensic Science Review. 2002;14: 134–151.
Weingarten HL, Trevias ER. Analysis of phencyclidine in blood by gas chromatography, radioimmunoassay, and enzyme immunoassay. Journal of Analytical Toxicology. 1982;6(2): 88–90. doi:10.1093/jat/6.2.88
Naso-Kaspar CK, Wyman JF, Clark CR, et al. In vitro formation of acetylmorphine from morphine and aspirin in postmortem gastric contents and deionized water. Journal of Analytical Toxicology. 2013;37(8): 500–506. doi:10.1093/jat/bkt064
Wu AHB, Wong SS, Johnson KG, et al. The conversion of ephedrine to methamphetamine and methamphetamine‐like compounds during and prior to gas chromatographic/mass spectrometric analysis of CB and HFB derivatives. Biological Mass Spectrometry. 1992;21(6): 278–284. doi:10.1002/bms.1200210603
Mahmoud AE, Stanford DF, Sherman D, et al. A procedure for eliminating interferences from ephedrine and related compounds in the gc/ms analysis of amphetamine and methamphetamine. Journal of Analytical Toxicology. 1992;16(2): 109–111. doi:10.1093/jat/16.2.109
Paul BD, Past MR, Mc Kinley RM, et al. Amphetamine as an artifact of methamphetamine during periodate degradation of interfering ephedrine, pseudoephedrine, and phenylpropanolamine: An improved procedure for accurate quantitation of amphetamines in urine. Journal of Analytical Toxicology. 1994;18(6): 331–336. doi:10.1093/jat/18.6.331
Galloway FR, Bellet NF. Methadone conversion to EDDP during GC-MS analysis of urine samples. Journal of Analytical Toxicology. 1999;23(7): 615–619. doi:10.1093/jat/23.7.615
Lewis RJ, Angier MK, Johnson RD. False carbamazepine positives due to 10,11-dihydro-10-hydroxycarbamazepine breakdown in the GC-MS injector port. Journal of Analytical Toxicology. 2014;38(8): 519–523. doi:10.1093/jat/bku064
Fu S, Lewis J, Wang H, et al. A novel reductive transformation of oxazepam to nordiazepam observed during enzymatic hydrolysis. Journal of Analytical Toxicology. 2010;34(5): 243–251. doi:10.1093/jat/34.5.243
Hearn WL, Walls HC. Introduction to post-mortem toxicology. In: Karch SB (ed.) Drug Abuse Handbook. 2nd ed. Boca Raton, FL: CRC Press; 2007. p. 965–975.
Richardson T. Pitfalls in forensic toxicology. Annals of Clinical Biochemistry. 2000;37(1): 20–44. doi:10.1258/0004563001901498
Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Science International. 2004;142(2–3): 101–113. doi:10.1016/j.forsciint.2004.02.013
Leikin JB, Watson WA. Post-mortem toxicology: What the dead can and cannot tell us. Journal of Toxicology - Clinical Toxicology. 2003;41(1): 47–56. doi:10.1081/CLT-120018270
Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Science International. 2004;142(2–3): 75–100. doi:10.1016/j.forsciint.2004.02.012
Høiseth G, Karinen R, Christophersen A, et al. Practical use of ethyl glucuronide and ethyl sulfate in postmortem cases as markers of antemortem alcohol ingestion. International Journal of Legal Medicine. 2010;124(2): 143–148. doi:10.1007/s00414-009-0393-0
Kugelberg FC, Jones AW. Interpreting results of ethanol analysis in postmortem specimens: A review of the literature. Forensic Science International. 2007;165(1): 10–29. doi:10.1016/j.forsciint.2006.05.004
CORRY JEL. Possible Sources of Ethanol Ante‐ and Post‐mortem: its Relationship to the Biochemistry and Microbiology of Decomposition. Journal of Applied Bacteriology. 1978;44(1): 1–56. doi:10.1111/j.1365-2672.1978.tb00776.x
Boumba VA, Economou V, Kourkoumelis N, et al. Microbial ethanol production: Experimental study and multivariate evaluation. Forensic Science International. Elsevier Ireland Ltd; 2012;215(1–3): 189–198. doi:10.1016/j.forsciint.2011.03.003
Høiseth G, Bernard JP, Karinen R, et al. A pharmacokinetic study of ethyl glucuronide in blood and urine: Applications to forensic toxicology. Forensic Science International. 2007;172(2–3): 119–124. doi:10.1016/j.forsciint.2007.01.005
Meatherall RC, Fraser AD. CEDIA dau Benzodiazepine screening assay: A reformulation. Journal of Analytical Toxicology. 1998;22(4): 270–273. doi:10.1093/jat/22.4.270
Kupiec T, DeCicco L, Spiehler V, et al. Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine. Journal of Analytical Toxicology. 2002;26(7): 513–518. doi:10.1093/jat/26.7.513
Tenore PL. Advanced urine toxicology testing. Journal of Addictive Diseases. 2010;29(4): 436–448. doi:10.1080/10550887.2010.509277
Taylor K, Elliott S. A validated hybrid quadrupole linear ion-trap LC-MS method for the analysis of morphine and morphine glucuronides applied to opiate deaths. Forensic Science International. 2009;187(1–3): 34–41. doi:10.1016/j.forsciint.2009.02.011
Skopp G, Pötsch L, Klingmann A, et al. Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples. Journal of Analytical Toxicology. 2001;25(1): 2–7. doi:10.1093/jat/25.1.2
Shipkova M, Armstrong VW, Oellerich M, et al. Acyl glucuronide drug metabolites: Toxicological and analytical implications. Therapeutic Drug Monitoring. 2003;25(1): 1–16. doi:10.1097/00007691-200302000-00001
Wester R, Noonan P, Markos C, et al. Identification of carbamate derivatives formed during chloroform extraction of tricyclic antidepressants from urine. Journal of Chromatography A. 1981;209(3): 463–466. doi:10.1016/S0021-9673(00)80618-4
Mohammadi A, Amini M, Hamedani MP, et al. Study of the formation of artifacts following dichloromethane reaction with some nitrogenous drugs. Asian Journal of Chemistry. 2008;20(7): 5573–5580.
Wille SMR, Lambert WEE. Recent developments in extraction procedures relevant to analytical toxicology. Analytical and Bioanalytical Chemistry. 2007;388(7): 1381–1391. doi:10.1007/s00216-007-1294-z
Juhascik M, Gleba J, Jenkins A. Formation of benzoylecgonine isopropyl ester following solid-phase extraction. Journal of Analytical Toxicology. 2012;36(2): 141–143. doi:10.1093/jat/bks001
Trafton JA, Ramani A. Methadone: A new old drug with promises and pitfalls. Current Pain and Headache Reports. 2009;13(1): 24–30. doi:10.1007/s11916-009-0006-0
Sauvage FL, Gaulier JM, Lachâtre G, et al. Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clinical Chemistry. 2008;54(9): 1519–1527. doi:10.1373/clinchem.2008.105478
Gadkariem EA, El-Obeid HA, Abounassif MA, et al. Effects of alkali and simulated gastric and intestinal fluids on danazol stability. Journal of Pharmaceutical and Biomedical Analysis. 2003;31(4): 743–751. doi:10.1016/S0731-7085(02)00660-X